Synapse - Works

Results (115372)

Primary hepatic lymphoma: Role of low-dose radiotherapy at a single institution with genetic characterization and paired literature review

Meeting Abstract

Ma, J.; Daou, R.; Eid, J. B.; Lee, J.; Fregonese, B.; El-Khoury, J.; Wijetunga, N. A.; Hubbeling, H.; Tringale, K. R.; Lebow, E. S.; more...
Blood (2022)

Fulltext@MSK | Save

Siremadlin in combination with venetoclax (VEN) plus azacitidine (AZA) in adult patients with acute myeloid leukemia (AML) who are ineligible for intensive chemotherapy: A phase Ib/II trial

Meeting Abstract

Daver, N.; Wei, A. H.; Stein, E.; DeAngelo, D. J.; Pathak, D.; Xu, Y.; Grzesiak, S.; Venditti, A.
Blood (2022)

Fulltext@MSK | Save

Dissecting the knowns for the unknowns: Refining the classification of genomic variations in hematological diseases by the ClinGen Hematological Cancer Taskforce (HCT)

Meeting Abstract

Li, Y.; Saliba, J.; Kopp, N.; Mani, C.; Williams, H. E.; Zhang, W.; Zhao, J.; Krysiak, K.; Danos, A.; Shao, X.; more...
Blood (2022)

Fulltext@MSK | Save

Dermatologic adverse events in acute lymphocytic leukemia patients treated with bispecific T-cell engager blinatumomab

Meeting Abstract

Parisi, R.; Cowen, E. A.; Gu, S.; Pulitzer, M.; Geyer, M. B.; King, A. C.; Markova, A.
Blood (2022)

Fulltext@MSK | Save

A phase 1b study of IDH inhibition with enasidenib and MEK inhibition with cobimetinib in patients with relapsed or refractory acute myeloid leukemia who have co-occurring IDH2 and RAS signaling gene mutations

Meeting Abstract

Ball, B. J.; Stein, E.; Robbins, M.; Zhang, J.; Levine, R. L.; Synold, T.; Stein, A. S.; Marcucci, G.; Liu, Y.; Danilov, A. V.
Blood (2022)

Fulltext@MSK | Save

Impact of polymorphisms in pharmacokinetic genes on tyrosine kinase inhibitor (TKI) tolerability in patients with chronic myeloid leukemia (CML) or Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL)

Meeting Abstract

Patel, J. N.; Lopes, K. E.; Druhan, L. J.; Zeng, H.; Beam, T.; Moore, D. C.; Salem, A.; Hamadeh, I.; Savage, Q.; Chojecki, A. L.; more...
Blood (2022)

Fulltext@MSK | Save

Improvement in individual symptoms and total symptom score (TSS) and matching-adjusted indirect comparison (MAIC) analysis to compare TSS as a continuous endpoint in patients with myelofibrosis treated with pelabresib in combination with ruxolitinib versus janus kinase inhibitor monotherapy

Meeting Abstract

Mesa, R.; Kremyanskaya, M.; Patriarca, A.; Gupta, V.; Palandri, F.; Devos, T.; Harrison, C.; Rampal, R. K.; Talpaz, M.; Vannucchi, A.; more...
Blood (2022)

Fulltext@MSK | Save

Comparison of patients with newly diagnosed (ND) acute myeloid leukemia (AML) treated with venetoclax and hypomethylating agents vs other therapies by TP53 and IDH1/2 mutation: Results from the AML Real World Evidence (ARC) Initiative

Meeting Abstract

Wolach, O.; Garcia, J. S.; Desai, P.; Vachhani, P.; Zeidner, J. F.; Abedin, S.; Sweet, K.; Lai, C.; Moshe, Y.; Pollyea, D. A.; more...
Blood (2022)

Fulltext@MSK | Save

Association of linguistic barriers and survival in allogeneic hematopoietic cell transplantation

Meeting Abstract

Walji, M.; Lee, J.; Devlin, S. M.; Gany, F.; Perales, M. A.; Giralt, S. A.; Cho, C.
Blood (2022)

Fulltext@MSK | Save

Estimating the lifetime medical cost burden of an allogeneic hematopoietic cell transplantation patient and the value of addressing the unmet need

Meeting Abstract

Maziarz, R. T.; Devine, S. M.; Garrison, L. P.; Agodoa, I.; Badaracco, J.; Gitlin, M.; Perales, M. A.
Blood (2022)

Fulltext@MSK | Save